Cargando…

Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using (18)F-fluoromisonidazole PET/CT: a pilot study

PURPOSE: Hypoxia is a major factor in prostate cancer aggressiveness and radioresistance. Predicting which patients might be bad candidates for radiotherapy may help better personalize treatment decisions in intermediate-risk prostate cancer patients. We assessed spatial distribution of (18)F-Misoni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Supiot, Stéphane, Rousseau, Caroline, Dore, Mélanie, Cheze-Le-Rest, Catherine, Kandel-Aznar, Christine, Potiron, Vincent, Guerif, Stéphane, Paris, François, Ferrer, Ludovic, Campion, Loïc, Meingan, Philippe, Delpon, Gregory, Hatt, Mathieu, Visvikis, Dimitris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839367/ https://www.ncbi.nlm.nih.gov/pubmed/29515786 http://dx.doi.org/10.18632/oncotarget.24234

Ejemplares similares

Can We Spare the Pancreas and Other Abdominal Organs at Risk? A Comparison of Conformal Radiotherapy, Helical Tomotherapy and Proton Beam Therapy in Pediatric Irradiation
por: Jouglar, Emmanuel, et al.
Publicado: (2016)

A new tissue segmentation method to calculate 3D dose in small animal radiation therapy
por: Noblet, C., et al.
Publicado: (2018)

Optimizing radiotherapy protocols using computer automata to model tumour cell death as a function of oxygen diffusion processes
por: Paul-Gilloteaux, Perrine, et al.
Publicado: (2017)

Radiogenomics in Colorectal Cancer
por: Badic, Bogdan, et al.
Publicado: (2021)

Accurate Tumor Delineation vs. Rough Volume of Interest Analysis for (18)F-FDG PET/CT Radiomics-Based Prognostic Modeling inNon-Small Cell Lung Cancer
por: Sepehri, Shima, et al.
Publicado: (2021)

Comparison and Fusion of Machine Learning Algorithms for Prospective Validation of PET/CT Radiomic Features Prognostic Value in Stage II-III Non-Small Cell Lung Cancer
por: Sepehri, Shima, et al.
Publicado: (2021)

Influence of Radiotherapy Fractionation Schedule on the Tumor Vascular Microenvironment in Prostate and Lung Cancer Models
por: Clément-Colmou, Karen, et al.
Publicado: (2020)

Correlation of Intra-Tumor (18)F-FDG Uptake Heterogeneity Indices with Perfusion CT Derived Parameters in Colorectal Cancer
por: Tixier, Florent, et al.
Publicado: (2014)

Revisiting the identification of tumor sub-volumes predictive of residual uptake after (chemo)radiotherapy: influence of segmentation methods on (18)F-FDG PET/CT images
por: Hatt, Mathieu, et al.
Publicado: (2019)

Transcriptomics in cancer revealed by Positron Emission Tomography radiomics
por: Tixier, Florent, et al.
Publicado: (2020)

Haute Couture or Ready-To-Wear? Tailored Pelvic Radiotherapy for Prostate Cancer Based on Individualized Sentinel Lymph Node Detection
por: Michaud, Anne-Victoire, et al.
Publicado: (2020)

Comparison of Hormone-Sensitive Oligorecurrent Prostate Cancer Patients Based on Routine Use of Choline and/or PSMA PET/CT to Guide Metastasis-Directed Therapy
por: Metz, Raphaël, et al.
Publicado: (2023)

A Monte Carlo Determination of Dose and Range Uncertainties for Preclinical Studies with a Proton Beam
por: Bongrand, Arthur, et al.
Publicado: (2021)

Interaction Between Modern Radiotherapy and Immunotherapy for Metastatic Prostate Cancer
por: Ollivier, Luc, et al.
Publicado: (2021)

Delineation of the Prostate Bed: The “Invisible Target” Is Still an Issue?
por: Latorzeff, Igor, et al.
Publicado: (2017)

Improved Functionality of the Vasculature during Conventionally Fractionated Radiation Therapy of Prostate Cancer
por: Potiron, Vincent A., et al.
Publicado: (2013)

Sentinel Lymph Node Biopsy: A Great Opportunity for Personalized Radiotherapy in Prostate Cancer
por: Supiot, Stéphane, et al.
Publicado: (2023)

(18)F-Fluoromisonidazole in tumor hypoxia imaging
por: Xu, Zuoyu, et al.
Publicado: (2017)

[(18)F]Fluoromisonidazole PET in rectal cancer
por: Puri, Tanuj, et al.
Publicado: (2017)

Targeting Stereotactic Body Radiotherapy on Metabolic PET- and Immuno-PET-Positive Vertebral Metastases
por: Pichon, Baptiste, et al.
Publicado: (2020)

Preclinical Evaluation of Intraoperative Low-Energy Photon Radiotherapy Using Spherical Applicators in Locally Advanced Prostate Cancer
por: Buge, François, et al.
Publicado: (2015)

The Sentinel Lymph Node in Treatment Planning: A Narrative Review of Lymph-Flow-Guided Radiotherapy
por: Ah-Thiane, Loic, et al.
Publicado: (2023)

OLIGOPELVIS – GETUG P07: a multicentre phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer
por: Supiot, Stephane, et al.
Publicado: (2015)

Oligometastatic prostate cancer: is it worth targeting the tip of the iceberg?
por: Supiot, Stéphane, et al.
Publicado: (2019)

microRNAs identified in prostate cancer: Correlative studies on response to ionizing radiation
por: Labbé, Maureen, et al.
Publicado: (2020)

Combined abiraterone acetate plus prednisone, salvage prostate bed radiotherapy and LH-RH agonists (CARLHA-GEP12) in biochemically-relapsing prostate cancer patients following prostatectomy: A phase I study of the GETUG/GEP
por: Supiot, Stéphane, et al.
Publicado: (2018)

Ultrahigh-Dose-Rate Proton Irradiation Elicits Reduced Toxicity in Zebrafish Embryos
por: Saade, Gaëlle, et al.
Publicado: (2022)

(18)F-fluoromisonidazole predicts evofosfamide uptake in pancreatic tumor model
por: Grkovski, Milan, et al.
Publicado: (2018)

Imaging of hypoxia in human glioblastoma with dynamic 18F-fluoromisonidazole PET
por: Abdo, Redha-Alla, et al.
Publicado: (2019)

Multicentric validation of radiomics findings: challenges and opportunities
por: Hatt, Mathieu, et al.
Publicado: (2019)

Monitoring vascular normalization induced by antiangiogenic treatment with 18F‐fluoromisonidazole‐PET
por: Hernández-Agudo, Elena, et al.
Publicado: (2015)

Comparison of Automated Atlas-Based Segmentation Software for Postoperative Prostate Cancer Radiotherapy
por: Delpon, Grégory, et al.
Publicado: (2016)

FDG PET/CT for rectal carcinoma radiotherapy treatment planning: comparison of functional volume delineation algorithms and clinical challenges
por: Withofs, Nadia, et al.
Publicado: (2014)

Evaluation of hypoxia in an experimental rat tumour model by [(18)F]Fluoromisonidazole PET and immunohistochemistry
por: Dubois, L, et al.
Publicado: (2004)

Biological characteristics of intratumoral [F-18]-fluoromisonidazole distribution in a rodent model of glioma
por: HATANO, TOSHIYUKI, et al.
Publicado: (2013)

Reproducibility of (18)F-fluoromisonidazole intratumour distribution in non-small cell lung cancer
por: Grkovski, Milan, et al.
Publicado: (2016)

Prospective evaluation of quality of life 54 months after high-dose intensity-modulated radiotherapy for localized prostate cancer
por: Goineau, Aurore, et al.
Publicado: (2013)

The Roles of Hypoxia Imaging Using (18)F-Fluoromisonidazole Positron Emission Tomography in Glioma Treatment
por: Hirata, Kenji, et al.
Publicado: (2019)

Post-Prostatectomy Image-Guided Radiotherapy: The Invisible Target Concept
por: Vilotte, Florent, et al.
Publicado: (2017)

Assessment of Lymph Nodes and Prostate Status Using Early Dynamic Curves with (18)F-Choline PET/CT in Prostate Cancer
por: Mathieu, Cédric, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_iqn3v5mo27s8g4odhr030ejmk3